Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Which drug has a definite risk of hemolysis in patients with G6PD deficiency?

Cotrimoxazole. Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is an X-linked recessive disorder where red blood cells lack the ability to regenerate reduced glutathione, making them vulnerable to oxidative stress [1]. When exposed to certain drugs [2], reactive oxygen species cause hemoglobin to precipitate (Heinz bodies), leading to hemolysis [2]. **Why Cotrimoxazole is correct:** Cotrimoxazole is a combination of Trimethoprim and **Sulfamethoxazole**. Sulfonamides are classic "high-risk" triggers for oxidative hemolysis in G6PD-deficient individuals [2]. They act as oxidizing agents that overwhelm the limited antioxidant capacity of the deficient RBCs. **Analysis of Incorrect Options:** * **Chloroquine (Option B):** While traditionally listed in older texts, recent evidence suggests that chloroquine (and hydroxychloroquine) carries a low risk of hemolysis at standard therapeutic doses. It is generally considered safe in most G6PD variants. * **Sulfasalazine (Option C):** Although it contains a sulfonamide moiety, its systemic absorption is relatively low compared to Sulfamethoxazole, making it a less frequent trigger than Cotrimoxazole in clinical practice. * **Quinine (Option D):** Quinine is considered a low-risk drug. While it can cause immune-mediated thrombocytopenia, it is not a primary trigger for oxidative hemolysis in G6PD deficiency. **NEET-PG High-Yield Pearls:** 1. **Definite Risk Drugs (Must Know):** Primaquine (most common trigger), Dapsone, Nitrofurantoin, Sulfamethoxazole, and Rasburicase [2]. 2. **The "Bite Cell" Connection:** Peripheral smear in G6PD deficiency typically shows **Heinz bodies** (supravital stain) and **Degmacytes (Bite cells)**. 3. **Inheritance:** It is the most common RBC enzyme deficiency worldwide (X-linked). 4. **Clinical Tip:** Always screen for G6PD deficiency before starting long-term Dapsone (for Leprosy) or Primaquine (for radical cure of P. vivax) [2].

Q: All are features of acute morphine poisoning, except?

Hyperpyrexia. ### Explanation Acute morphine poisoning (Opioid Overdose) is characterized by a classic clinical triad. Understanding the physiological effects of opioids on the central nervous system (CNS) and autonomic nervous system is key to identifying the correct answer. **Why Hyperpyrexia is the correct answer:** Morphine and other opioids typically cause **hypothermia**, not hyperpyrexia. This occurs due to the depression of the hypothalamic temperature-regulating center and a decrease in metabolic rate. * *Note:* Hyperpyrexia is more characteristic of **Atropine** poisoning or **Serotonin Syndrome**. **Analysis of incorrect options:** * **Pin-point pupil (Miosis):** Morphine stimulates the **Edinger-Westphal nucleus** of the 3rd cranial nerve. This is a hallmark sign, though terminal hypoxia may cause pupils to dilate just before death. * **Fall in blood pressure (Hypotension):** Morphine causes peripheral vasodilation due to **histamine release** and depression of the vasomotor center in the medulla. * **Slow labored breathing:** Respiratory depression is the most dangerous complication. Morphine reduces the sensitivity of the respiratory center to $CO_2$, leading to a decreased respiratory rate (often <10 breaths/min) and cyanosis. **Clinical Pearls for NEET-PG:** 1. **The Opioid Triad:** Coma, Pin-point pupil, and Respiratory depression. 2. **Specific Antidote:** **Naloxone** is the drug of choice (pure opioid antagonist). It has a shorter half-life than morphine, so repeated doses may be necessary. 3. **Exceptions to Miosis:** Pethidine (Meperidine) poisoning often presents with **mydriasis** (dilated pupils) due to its atropine-like (antimuscarinic) action. 4. **Cause of Death:** In acute morphine poisoning, death usually occurs due to **respiratory failure**.

Q: What is the primary treatment for methemoglobinemia?

Methylene blue. **Explanation:** **Methemoglobinemia** occurs when the iron in hemoglobin is oxidized from the ferrous state (**Fe²⁺**) to the ferric state (**Fe³⁺**). Ferric iron cannot bind oxygen and causes a "left shift" in the dissociation curve, leading to tissue hypoxia and characteristic "chocolate-colored blood." **1. Why Methylene Blue is correct:** Methylene blue acts as an exogenous electron donor. In the presence of **NADPH-methemoglobin reductase**, it is converted to leucomethylene blue. This metabolite then reduces the ferric iron (Fe³⁺) back to the functional ferrous state (Fe²⁺), restoring the oxygen-carrying capacity of hemoglobin. **2. Why other options are incorrect:** * **Hydroxyurea:** Used in Sickle Cell Anemia to increase Fetal Hemoglobin (HbF) levels; it does not treat acute oxidation states. * **Fava beans:** These are a known trigger for oxidative stress in **G6PD deficiency**, which can actually *cause* hemolysis and exacerbate methemoglobinemia. * **Exchange transfusion:** This is a second-line treatment reserved for severe cases where methylene blue is ineffective or contraindicated (e.g., G6PD deficiency). **Clinical Pearls for NEET-PG:** * **Classic Presentation:** Cyanosis that does not improve with supplemental oxygen and a "saturation gap" (difference between SpO₂ on pulse oximetry and SaO₂ on ABG). * **Common Triggers:** Nitrites, Benzocaine (local anesthetic), Dapsone, and Sulfonamides. * **Contraindication:** Methylene blue is **contraindicated in G6PD deficiency** because it requires NADPH (produced by G6PD) to work; using it can trigger severe hemolysis. In such patients, use **Vitamin C (Ascorbic acid)** or exchange transfusion.

Q: Which metabolic abnormality is caused by cyclosporine?

Hyperkalemia. **Explanation:** Cyclosporine is a Calcineurin Inhibitor (CNI) widely used as an immunosuppressant in organ transplantation and autoimmune disorders. **Why Hyperkalemia is correct:** Cyclosporine causes **Hyperkalemia** primarily through two mechanisms: 1. **Renal Vasoconstriction:** It induces potent vasoconstriction of the afferent arterioles, reducing renal blood flow and the Glomerular Filtration Rate (GFR). 2. **Hyporeninemic Hypoaldosteronism:** It suppresses the production of renin and aldosterone. Reduced aldosterone levels lead to decreased potassium excretion in the distal nephron [1]. Additionally, it inhibits the mineralocorticoid receptor-mediated sodium-potassium exchange, further elevating serum potassium levels. **Why other options are incorrect:** * **Hypokalemia:** This is incorrect because cyclosporine consistently impairs potassium excretion rather than promoting it. * **Hypercalcemia/Hypocalcemia:** Cyclosporine does not significantly impact calcium homeostasis directly. However, it is more commonly associated with **Hypomagnesemia** due to renal magnesium wasting. **High-Yield Clinical Pearls for NEET-PG:** * **The "Hyper" Mnemonic for Cyclosporine side effects:** **Hyper**kalemia, **Hyper**tension, **Hyper**lipidemia, **Hyper**glycemia, and **Hyper**trichosis (Hirsutism). * **Gingival Hyperplasia:** A classic physical finding associated with cyclosporine (also seen with Phenytoin and Nifedipine). * **Nephrotoxicity:** This is the most common dose-limiting side effect. * **Comparison:** Unlike Cyclosporine, **Tacrolimus** (another CNI) does not cause hirsutism or gingival hyperplasia but is more likely to cause post-transplant diabetes mellitus.

Q: A child presents with tachycardia, bronchodilation, elevated temperature, and constipation, suggesting the ingestion of a particular substance. Which of the following is the most likely substance ingested?

Atropine. ### Explanation The clinical presentation described—**tachycardia, bronchodilation, hyperthermia (elevated temperature), and constipation**—is a classic manifestation of **Anticholinergic Syndrome**. **1. Why Atropine is Correct:** Atropine is a competitive antagonist of muscarinic acetylcholine receptors. By blocking the parasympathetic nervous system (the "rest and digest" system), it leads to sympathetic overactivity: * **Tachycardia:** Blockade of M2 receptors in the SA node. * **Bronchodilation:** Blockade of M3 receptors in bronchial smooth muscle. * **Constipation:** Decreased gastrointestinal motility (M3 blockade). * **Elevated Temperature:** Inhibition of sweat glands (M3 blockade), leading to "Atropine fever," especially in children. **2. Why the Other Options are Incorrect:** * **Nerium Odorum (Oleander):** Contains cardiac glycosides. Toxicity typically presents with **bradycardia**, heart blocks, and hyperkalemia (similar to Digoxin). * **Mushroom:** Most poisonous mushrooms (like *Amanita muscaria*) contain muscarine, which causes **Cholinergic symptoms** (SLUDGE: Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis) and bradycardia. * **Organophosphorus (OP):** These inhibit acetylcholinesterase, leading to an excess of acetylcholine. This causes **miosis (pinpoint pupils), bradycardia, and increased secretions** (the opposite of the question's presentation). **3. Clinical Pearls for NEET-PG:** * **Mnemonic for Atropine Poisoning:** "Hot as a hare (fever), Red as a beet (flushing), Dry as a bone (no sweat/saliva), Blind as a bat (mydriasis/cycloplegia), and Mad as a hatter (delirium)." * **Drug of Choice for Atropine Poisoning:** **Physostigmine** (a tertiary amine carbamate that crosses the blood-brain barrier). * **High-Yield Fact:** Atropine is contraindicated in patients with Narrow-Angle Glaucoma and Benign Prostatic Hyperplasia (BPH).

Q: Which of the following drugs can cause aplastic anemia?

All of the above. **Explanation:** Aplastic anemia is a life-threatening condition characterized by pancytopenia (reduction in RBCs, WBCs, and platelets) resulting from bone marrow suppression. In clinical pharmacology, drug-induced aplastic anemia is often an **idiosyncratic type B reaction**, meaning it is unpredictable, not dose-dependent, and carries high mortality [1]. **Analysis of Options:** * **Chlorpromazine:** This typical antipsychotic is a well-documented cause of blood dyscrasias. While agranulocytosis is more common, it can rarely progress to full bone marrow failure (aplastic anemia) [1]. * **Allopurinol:** Used for chronic gout, this xanthine oxidase inhibitor is associated with severe hypersensitivity reactions (DRESS syndrome) and rare instances of bone marrow suppression leading to aplastic anemia. * **Diclofenac:** Among NSAIDs, while phenylbutazone is the most notorious for aplastic anemia, diclofenac and indomethacin are also recognized triggers for idiosyncratic marrow suppression. Since all three drugs are clinically recognized causes of this condition, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Trigger:** **Chloramphenicol** is the most frequently asked drug associated with aplastic anemia (occurs in 1 in 20,000–40,000 patients). * **Other Key Culprits:** Carbamazepine, Phenytoin, Gold salts, Penicillamine, and Sulfonamides. * **Mechanism:** Most drug-induced aplastic anemias are immune-mediated, where the drug or its metabolite acts as a hapten, triggering T-cell-mediated destruction of hematopoietic stem cells. * **Management:** Immediate withdrawal of the offending drug; definitive treatment may require Bone Marrow Transplantation or immunosuppressants (Antithymocyte globulin + Cyclosporine).

Q: Which of the following drugs does not cause nephrotoxicity?

Sirolimus. **Explanation:** The correct answer is **Sirolimus (Option D)**. **Why Sirolimus is the correct answer:** Sirolimus (Rapamycin) is an mTOR inhibitor used as an immunosuppressant. Unlike Calcineurin inhibitors (CNIs), it is notably **non-nephrotoxic** [1]. In clinical practice, it is often used as an alternative to switch patients who develop renal impairment while on drugs like Cyclosporine or Tacrolimus [1], [2]. Its primary side effects are hyperlipidemia, thrombocytopenia, and impaired wound healing [1]. **Why the other options are incorrect:** * **Cisplatin (Option A):** A platinum-based chemotherapeutic agent notorious for causing **Acute Tubular Necrosis (ATN)**. It is the most nephrotoxic drug in its class. Nephrotoxicity is dose-limiting and can be mitigated by aggressive hydration and Amifostine. * **Cyclophosphamide (Option B):** While primarily known for causing **Hemorrhagic Cystitis** (due to the metabolite Acrolein), it can cause nephrotoxicity in the form of SIADH (water retention) and, at high doses, direct tubular damage [3]. * **Cyclosporine (Option C):** A Calcineurin inhibitor that causes nephrotoxicity via **afferent arteriolar vasoconstriction** [4], [5]. This leads to decreased GFR and, with chronic use, interstitial fibrosis (striped fibrosis). **High-Yield Clinical Pearls for NEET-PG:** 1. **Amifostine** is a cytoprotective agent used specifically to reduce Cisplatin-induced nephrotoxicity. 2. **Mesna** (2-Mercaptoethane sulfonate) is used to prevent Hemorrhagic Cystitis caused by Cyclophosphamide/Ifosfamide. 3. **Tacrolimus vs. Sirolimus:** Both bind to FKBP-12, but Tacrolimus inhibits Calcineurin (nephrotoxic), while Sirolimus inhibits mTOR (non-nephrotoxic) [1]. 4. **Drug of choice** for reversing CNI-induced renal vasoconstriction: Calcium Channel Blocks (CCBs).

Q: What is the specific antidote for poisoning due to metoprolol?

Glucagon. ### Explanation **Correct Answer: C. Glucagon** **Mechanism of Action:** Metoprolol is a selective $\beta_1$-blocker. In cases of severe overdose, $\beta$-receptors are occupied, leading to bradycardia and hypotension. **Glucagon** is the drug of choice because it bypasses the blocked $\beta$-adrenergic receptors. It acts on specific **G-protein coupled glucagon receptors** on the myocardium, which stimulates **adenylyl cyclase**. This increases intracellular **cAMP** levels, leading to positive inotropic (increased contractility) and chronotropic (increased heart rate) effects, effectively reversing the cardiac depression caused by the blocker. **Why other options are incorrect:** * **Atropine (A):** While it is an anticholinergic used for symptomatic bradycardia, it is often ineffective in severe $\beta$-blocker toxicity because it cannot overcome the profound suppression of the conduction system. * **Isoproterenol (B):** This is a non-selective $\beta$-agonist. In the presence of a massive $\beta$-blocker overdose, the receptors are competitively occupied; extremely high doses of isoproterenol would be required, which can lead to severe peripheral vasodilation and worsening hypotension. * **Verapamil (D):** This is a Calcium Channel Blocker (CCB). Administering Verapamil would be contraindicated as it would exacerbate the bradycardia and myocardial depression. **High-Yield Clinical Pearls for NEET-PG:** 1. **First-line management:** Initial steps include IV fluids and Atropine, but **Glucagon** is the specific antidote for refractory cases. 2. **Other treatments:** If Glucagon fails, **High-dose Insulin Euglycemic Therapy (HIET)** and IV lipid emulsion are considered. 3. **Key distinction:** Glucagon is also the antidote for **Calcium Channel Blocker** poisoning, though HIET is often preferred there. 4. **Side effect:** A common side effect of high-dose Glucagon administration is **vomiting**; ensure airway protection.

Q: Which of the following drugs does NOT cause gynecomastia?

Pyrazinamide. **Explanation:** Gynecomastia is the benign proliferation of glandular breast tissue in males, typically caused by an imbalance between estrogen and androgen action [1]. **Why Pyrazinamide is the correct answer:** Pyrazinamide is a first-line antitubercular drug (part of RIPE therapy) [2]. Its primary side effects include **hyperuricemia** (leading to gout) and **hepatotoxicity** [2]. It does not interfere with sex hormone synthesis or receptors and, therefore, does not cause gynecomastia. Among antitubercular drugs, **Isoniazid (INH)** is the one classically associated with gynecomastia (likely due to its effect on hepatic metabolism of hormones). **Analysis of incorrect options:** * **Cimetidine:** An H2-receptor antagonist that causes gynecomastia by two mechanisms: it acts as a weak androgen receptor antagonist and inhibits the cytochrome P450-mediated hydroxylation of estradiol, leading to increased estrogen levels. * **Spironolactone:** A potassium-sparing diuretic that is a common cause of gynecomastia. It blocks androgen receptors and increases the peripheral conversion of testosterone to estradiol [1]. * **Ketoconazole:** An antifungal that inhibits the enzyme **17,20-desmolase** (CYP17), which is essential for steroid and testosterone synthesis [1]. Decreased testosterone leads to a relative increase in estrogen. **High-Yield Clinical Pearls for NEET-PG:** To remember the common drugs causing gynecomastia, use the mnemonic **"DISCO"**: * **D**igoxin * **I**soniazid * **S**pironolactone * **C**imetidine * **O**estrogens / **K**etoconazole (often added as DISCO-K) Other notable causes include **Finasteride** (5-alpha reductase inhibitor) and **Risperidone** (via hyperprolactinemia).

Question 1

Which drug has a definite risk of hemolysis in patients with G6PD deficiency?

Accepted Answer

Cotrimoxazole

Answer

Chloroquine

Answer

Sulfasalazine

Answer

Quinine

Question 2

All are features of acute morphine poisoning, except?

Accepted Answer

Hyperpyrexia

Answer

Pin-point pupil

Answer

Fall in blood pressure

Answer

Slow labored breathing

Question 3

What is the primary treatment for methemoglobinemia?

Accepted Answer

Methylene blue

Answer

Hydroxyurea

Answer

Fava beans

Answer

Exchange transfusion

Question 4

Which metabolic abnormality is caused by cyclosporine?

Accepted Answer

Hyperkalemia

Answer

Hypokalemia

Answer

Hypercalcemia

Answer

Hypocalcemia

Question 5

Which of the following drugs does not cause postural hypotension?

Accepted Answer

ACE inhibitor

Answer

Prazosin

Answer

Phentolamine

Answer

Levodopa

Question 6

A child presents with tachycardia, bronchodilation, elevated temperature, and constipation, suggesting the ingestion of a particular substance. Which of the following is the most likely substance ingested?

Accepted Answer

Atropine

Answer

Nerium Odorum

Answer

Mushroom

Answer

Organophosphorus

Question 7

Which of the following drugs can cause aplastic anemia?

Accepted Answer

All of the above

Answer

Chlorpromazine

Answer

Allopurinol

Answer

Diclofenac

Question 8

Which of the following drugs does not cause nephrotoxicity?

Accepted Answer

Sirolimus

Answer

Cisplatin

Answer

Cyclophosphamide

Answer

Cyclosporine

Question 9

What is the specific antidote for poisoning due to metoprolol?

Accepted Answer

Glucagon

Answer

Atropine

Answer

Isoproterenol

Answer

Verapamil

Question 10

Which of the following drugs does NOT cause gynecomastia?

Accepted Answer

Pyrazinamide

Answer

Cimetidine

Answer

Spironolactone

Answer

Ketoconazole

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?